Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Jeremy Rubinstein

Assistant Professor

Cincinnati Children's Hospital Medical Center

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

50%

Virology

40%

Graft-versus-host Disease

40%

T Cell Biology

40%

Pediatric Oncology

30%

Antiviral Therapy

30%

Hematology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Outcomes with Third Party Virus Specific T-cells After the Use of Single Antigen Cell Lines to Predict HLA Restriction

Article Link

Year:

2025

Posttransplant EBV‐Positive Smooth Muscle Tumors in Children, Adolescents, and Young Adults: A Multi‐Institution Experience

Article Link

Year:

2025

The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL

Article Link

Year:

2023

Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy

Article Link

Year:

2023

Durable remissions achieved with reinfusion of CD19‐directed CAR‐T despite failure to induce or maintain B‐cell aplasia and single‐center experience with reinfusion of tisagenlecleucel

Article Link

Year:

2023

Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients

Article Link

Year:

2022

Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant

Article Link

Year:

2022

Acute myeloid leukemia in SRP54‐mutated congenital neutropenia

Article Link

Year:

2022

Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short‐course EPOCH regimens are safe and effective

Article Link

Year:

2021

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted.

Article Link

Year:

2021

Tolerance of dinutuximab therapy for treatment of high‐risk neuroblastoma in two patients with end‐stage renal disease on dialysis

Article Link

Year:

2021

Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy

Article Link

Year:

2020

Collaborators9

Christopher Dandoy

department of pediatrics university of cincinnati college of medicine cincinnati ohio usa

UNITED STATES

Thomas Galletta

Assistant Professor of Clinical Pediatrics

Cincinnati Children's Hospital Medical Center

UNITED STATES

Lauren Pommert

Assistant Professor

University of Cincinnati

UNITED STATES

Robin Norris

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

Lynn Lee

Research Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

Maureen O'Brien

Associate Professor of Clinical Pediatrics

University of Cincinnati

UNITED STATES

Catherine M. Bollard

Director/Professor

UNITED STATES

Patrick Hanley

Associate Professor

George Washington University

UNITED STATES

Michael S. Grimley

University of Cincinnati College of Medicine

UNITED STATES

How do I reach out?

Meet Kite AI